View in EDS HTML Full Text PDF Full Text

Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain.

Saved in:
Bibliographic Details
Title: Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain.
Authors: Rayson, Daniel1 daniel.rayson@nshealth.ca, Gandhi, Sonal2, Joy, Anil A.3, Brezden-Masley, Christine4, Gelmon, Karen A.5, Sehdev, Sandeep6, Cescon, David7, Chia, Stephen5
Source: Current Oncology. Dec2022, Vol. 29 Issue 12, p9891-9895. 5p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 160977681
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Rayson%2C+Daniel%22">Rayson, Daniel</searchLink><relatesTo>1</relatesTo><i> daniel.rayson@nshealth.ca</i><br /><searchLink fieldCode="AR" term="%22Gandhi%2C+Sonal%22">Gandhi, Sonal</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Joy%2C+Anil+A%2E%22">Joy, Anil A.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Brezden-Masley%2C+Christine%22">Brezden-Masley, Christine</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Gelmon%2C+Karen+A%2E%22">Gelmon, Karen A.</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Sehdev%2C+Sandeep%22">Sehdev, Sandeep</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Cescon%2C+David%22">Cescon, David</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Chia%2C+Stephen%22">Chia, Stephen</searchLink><relatesTo>5</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Current+Oncology%22">Current Oncology</searchLink>. Dec2022, Vol. 29 Issue 12, p9891-9895. 5p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=160977681
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/curroncol29120778
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 5
        StartPage: 9891
    Titles:
      – TitleFull: Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rayson, Daniel
      – PersonEntity:
          Name:
            NameFull: Gandhi, Sonal
      – PersonEntity:
          Name:
            NameFull: Joy, Anil A.
      – PersonEntity:
          Name:
            NameFull: Brezden-Masley, Christine
      – PersonEntity:
          Name:
            NameFull: Gelmon, Karen A.
      – PersonEntity:
          Name:
            NameFull: Sehdev, Sandeep
      – PersonEntity:
          Name:
            NameFull: Cescon, David
      – PersonEntity:
          Name:
            NameFull: Chia, Stephen
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: Dec2022
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 11980052
          Numbering:
            – Type: volume
              Value: 29
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Current Oncology
              Type: main
ResultId 1